Clinical Trials List
2011-01-01 - 2011-12-31
Phase IV
Terminated6
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳柏樟 Division of Rheumatology
- SONG-CHOU HSIEH Division of Rheumatology
- CHENG-HAN WU Division of Rheumatology
- KO-JEN LI Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳政宏 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 謝祖怡 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- Yi-Hsing Chen Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林逸君 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
0 participants
